National Bank of Canada’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$70.6M Buy
1,950
+1,495
+329% +$512K 0.05% 282
2026
Q1
$16M Sell
455
-266
-37% -$94.8K 0.01% 550
2025
Q4
$23.6M Buy
+721
New +$229K 0.02% 474
2025
Q3
– Sell
-2,950
Closed -$82.4M – 2841
2025
Q2
$82.4M Buy
+2,950
New +$836K 0.08% 213
2024
Q4
– Sell
-400
Closed -$12.9M – 2928
2024
Q3
$12.9M Buy
+400
New +$131K 0.01% 603
2024
Q1
– Sell
-1,525
Closed -$45.4M – 2723
2023
Q4
$45.4M Sell
1,525
-19
-1% -$5.18K 0.07% 248
2023
Q3
$41.1M Buy
+1,544
New +$385K 0.06% 267
2022
Q3
– Sell
-2,000
Closed -$48.7M – 2684
2022
Q2
$48.7M Buy
+2,000
New +$490K 0.22% 109

Other funds holding AMGN

National Bank of Canada's AMGN Position: Q2 2026 in Review

National Bank of Canada increased its Amgen (AMGN) stake by 2.2% in Q2 2026, buying an estimated $3.16M and bringing the position to 430,230 shares worth $156M. The position accounts for 0.11% of the portfolio, ranked #154.

National Bank of Canada first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $346M in Q3 2025. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • National Bank of Canada held 430,230 shares of Amgen worth $156M as of Q2 2026.
  • National Bank of Canada bought 9,237 Amgen shares in Q2 2026, an estimated $3.16M.
  • Amgen made up 0.11% of National Bank of Canada's portfolio in Q2 2026, its #154 holding.
  • National Bank of Canada first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
  • National Bank of Canada's Amgen position peaked at $346M in Q3 2025.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.